Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis

NCT03252600 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Primary Amyloidosis

Interventions

DRUG: Cyclophosphamide
DRUG: Dexamethasone
BIOLOGICAL: Elotuzumab
OTHER: Laboratory Biomarker Analysis
DRUG: Lenalidomide
OTHER: Pharmacological Study

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]